LUCIBELLO, MARIA
 Distribuzione geografica
Continente #
EU - Europa 31
AS - Asia 2
Totale 33
Nazione #
IT - Italia 30
CN - Cina 1
KR - Corea 1
NL - Olanda 1
Totale 33
Città #
Aversa 22
Rome 7
Amsterdam 1
Guangzhou 1
Modena 1
Seoul 1
Totale 33
Nome #
Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release 19
Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy 3
Molecular definition of the role of Nerve Growth Factor (NGF) in the immune response 3
A Novel 3D Scaffold for Cell Growth to Assess Electroporation Efficacy 3
DHA Affects Microtubule Dynamics Through Reduction of Phospho-TCTP Levels and Enhances the Antiproliferative Effect of T-DM1 in Trastuzumab-Resistant HER2-Positive Breast Cancer Cell Lines 2
Reduced susceptibility of NK cells to cancer cells is associated with long term NK cell culture and over-expression of TIMP3 2
Phospho-TCTP as a therapeutic target of dihydroartemisinin for aggressive breast cancer cells 2
Nerve Growth Factor inhibits apoptosis via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation and cytochrome c release", 1
Bcl-2 Phosphorylation by p38 MAPK: identification of target sites and biologic consequences. 1
Interferon-alpha e Interleuchina-2 come induttori sinergici della crescita endoteliale in vitro e in vivo. 1
Nerve Growth Factor inhibits apoptosis via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation and cytochrome c release", 1
Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation. 1
Totale 39
Categoria #
all - tutte 366
article - articoli 176
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 23
Totale 565


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202437 0 0 0 0 0 0 0 0 11 1 20 5
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 39